ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $48,326,000 | +120.3% | 1,128,594 | 0.0% | 0.96% | +28.9% |
| Q1 2020 | $21,940,000 | -25.2% | 1,128,594 | 0.0% | 0.74% | -13.9% |
| Q4 2019 | $29,321,000 | -4.7% | 1,128,594 | 0.0% | 0.86% | -32.9% |
| Q3 2019 | $30,760,000 | +1.5% | 1,128,594 | 0.0% | 1.28% | +22.4% |
| Q2 2019 | $30,303,000 | +1.7% | 1,128,594 | 0.0% | 1.05% | -18.6% |
| Q1 2019 | $29,793,000 | +7.4% | 1,128,594 | +0.0% | 1.29% | -22.4% |
| Q4 2018 | $27,753,000 | – | 1,128,584 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |